Skip to main content
. 2020 May 6;35(5):1145–1158. doi: 10.1093/humrep/deaa077

Table I.

Demographic data and clinic characteristics of participants.

Parameters Control (n = 25) PCOS (n = 25) P valueb
Age (years) 29.28 ± 4.43 28.88 ± 3.24 0.122
BMI (kg/m2) 21.06 ± 2.57 22.13 ± 2.50 0.112
Infertility duration (years) 2.68 ± 2.16 3.06 ± 1.92 0.382
Cycle length (days) 31.76 ± 3.43 52.16 ± 29.68 0.001
Anti-Müllerian hormone (ng/ml) 4.83 ± 2.02 11.95 ± 6.27 0.000
Baseline LH (IU/l) 3.72 ± 1.84 10.20 ± 6.80 0.007
Baseline FSH (IU/l) 6.81 ± 1.94 6.44 ± 1.64 0.383
LH/FSH 0.54 ± 0.22 1.60 ± 1.04 0.004
Baseline total testosterone (ng/ml) 0.48 ± 0.13 0.70 ± 0.29 0.054
Baseline oestradiol (ng/l) 79.86 ± 99.52 50.32 ± 32.90 0.121
Baseline progesterone (pg/l) 14.27 ± 5.29 17.77 ± 18.01 0.181
Triglycerides (mmol/l) 0.8 ± 0.5 1.2 ± 0.6 0.011
Total cholesterol (mmol/l) 4.5 ± 1.1 5.2 ± 1.2 0.021
Fasting glucose (mmol/l) 4.9 ± 0.4 5.9 ± 1.1 0.025
Fasting insulin (μU/ml) 4.9 ± 1.0 7.2 ± 1.1 0.010
HOMA-IRa median (quartiles) 1.0 (0.7, 1.4) 1.9 (1.4, 2.6) 0.026
Total testosterone in follicular fluid (ng/ml) 7.95 ± 2.48 11.34 ± 4.47 0.001

Data are mean ± SEM unless stated otherwise

aHOMA-IR, homeostasis model assessment of insulin resistance.

bUnpaired t test